Development of a Monoclonal Antibody Targeting HTLV-1 Envelope gp46 Glycoprotein and Its Application to Near-Infrared Photoimmuno-Antimicrobial Strategy
Authors:
- Yasuyoshi HatayamaYHYasuyoshi Hatayama
- Yutaro YamaokaYYYutaro Yamaoka
- Takeshi MoritaTMTakeshi Morita
- Sundararaj Stanleyraj JeremiahSundararaj Stanleyraj Jeremiah
- Kei MiyakawaKMKei Miyakawa
- Mayuko NishiMNMayuko Nishi
- Yayoi KimuraYKYayoi Kimura
- Makoto MitsunagaMMMakoto Mitsunaga
- Tadayuki IwaseTITadayuki Iwase
- Hirokazu KimuraHirokazu Kimura
- Naoki YamamotoNYNaoki Yamamoto
- Akifumi Takaori-KondoATAkifumi Takaori-Kondo
Open Access
Abstract
Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus, causes adult T-cell leukemia-lymphoma, HTLV-1 associated myelopathy/tropical spastic paraparesis, and HTLV-1 uveitis. Currently, no antiretroviral therapies or vaccines are available for HTLV-1 infection. This study aimed to develop an antibody against the HTLV-1 envelope protein (Env) and apply it to a near-infrared photoimmuno-antimicrobial strategy (NIR-PIAS) to eliminate HTLV-1 infected cells. We established mouse monoclonal antibodies (mAbs) against HTLV-1 Env by immunization with a complex of liposome and the recombinant protein. Detailed epitope mapping revealed that one of the mAbs bound to the proline-rich region of gp46 and exhibited no obvious neutralizing activity to inhibit viral infection. Instead, the mAb was rarely internalized intracellularly and remained on the cell surface of HTLV-1-infected cells. The antibody conjugated to the photosensitive dye IRDye700Dx recognized HTLV-1 infected cells and killed them following NIR irradiation. These results suggest that the novel mAb and NIR-PIAS could be developed as a new targeted therapeutic tool against HTLV-1 infected cells.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP22fk0108125)
This publication has 73 references indexed in Scilit:
- Epidemiological Aspects and World Distribution of HTLV-1 InfectionFrontiers in Microbiology, 2012
- Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane moleculesNature Medicine, 2011
- Molecular Aspects of HTLV-1 Entry: Functional Domains of the HTLV-1 Surface Subunit (SU) and Their Relationships to the Entry ReceptorsViruses, 2011
- Production and partial purification of membrane proteins using a liposome-supplemented wheat cell-free translation systemBMC Biotechnology, 2011
- Current concepts regarding the HTLV-1 receptor complexRetrovirology, 2010
- Intersubunit Disulfide Isomerization Controls Membrane Fusion of Human T-Cell Leukemia Virus EnvJournal of Virology, 2008
- An N-terminal glycine-rich sequence contributes to retrovirus trimer of hairpins stabilityBiochemical and Biophysical Research Communications, 2007
- Neuropilin-1 Is Involved in Human T-Cell Lymphotropic Virus Type 1 EntryJournal of Virology, 2006
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980